Navigation Links
Pharsight Hosts Fourth Annual PKS User Group Meeting
Date:9/28/2007

the FDA's regulation 21 CFR Part 11, which has set new standards for computer system validation and usage. PKS is directly integrated with WinNonlin(R) Enterprise(TM), Pharsight's industry-leading PK/PD modeling and analysis tool for state-of-the-art modeling and analyses, and supports direct access to any ODBC-capable data source. PKS also supports analysis with leading tools such as NONMEM(R) and SAS(R), and data import from leading clinical data management and laboratory information management systems such as Watson LIMS(TM). PKS software is designed to complement other Pharsight products, including Trial Simulator(TM) and Drug Model Explorer(R) (DMX(R)), which are used for computer-based drug-disease modeling, clinical trial simulation, and drug model visualization.

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.

Registered Trademarks and Trademarks

Pharsight, Pharsight Knowledgebase Server (PKS), WinNonlin Enterprise, Trial Simulator and Drug Model Explorer (DMX), are trademarks or registered trademarks of Pharsight Corporation. All other brand and product names are trademarks o
'/>"/>

SOURCE Pharsight Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Bacterial RNA Isolation From Infected Eukaryotic Hosts
2. Bacterial RNA Isolation From Infected Eukaryotic Hosts
3. High Tech Happy Hour will mark fourth anniversary
4. Niceware releases fourth version of labeling software
5. Wisconsin-based Third Wave reports increased revenue for 2003, fourth quarter
6. NameProtect releases annual list of top trademarkers
7. Doyle says new contracts saving state more than $16 million annually
8. Department of Commerce offers up to $1 million annually to aid tech entrepreneurs
9. Annual Bioethics Forum to explore genetic testing
10. Annual Conference Honors Tech Grant Winners
11. Cardinal Health likes growth potential of Viasys NeuroCare Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... , April 16, 2015 Avelas Biosciences, an ... improving cancer surgeries, announced today that it has initiated ... illuminator, AVB-620, in women with primary, non-recurrent breast cancer ... also welcomed the addition of Steven Chen , ... The open label, dose escalation study will enroll up ...
(Date:4/16/2015)... Switzerland , April 16, 2015 ... of Debiopharm Group ™ , a Swiss-based global ... unmet medical needs as well as companion ... the investigational compounds Debio 1143 (SMAC mimetic) and ... at the 2015 Annual meeting of the ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 Fairleigh ... Joseph V. Gulfo to become the Executive Director ... Simultaneously, FDU announced the kick-off of the Initiative ... spearheaded by Dr. Gulfo, under the Rothman Institute ... of Business) and in collaboration with FDU’s School ...
(Date:4/16/2015)... Dana-Farber Cancer Institute and its ... Bioscience, Inc. today announced the successful completion of ... clinic ready, Next Generation Sequencing (NGS) assay for ... the first to demonstrate the successful sequencing of ... blinded plasma samples and highlights the ability to ...
Breaking Biology Technology:Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 2Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 3
... two British education officals visited Madison to determine ... a time when many Wisconsin leaders are studying ... regions, it is ironic that across the Atlantic, ... and have turned to Wisconsin to export an ...
... -- Aurora Health Care is planning to open a ... new digital hospital will include the latest in digital ... physicians will benefit from enterprise storage and distribution of ... , ,Aurora Health Care established in 1984 is ...
... and political expertise motivates Wisconsins State Senator to trim ... and services. We want to stimulate venture ... to qualified venture funds as well as expand the ... create a bi-partisan effort to pass an end-to-end economic ...
Cached Biology Technology:Aurora Selects New Imaging Technology 2WTN Interview: Senator Ted Kanavas 2WTN Interview: Senator Ted Kanavas 3WTN Interview: Senator Ted Kanavas 4WTN Interview: Senator Ted Kanavas 5WTN Interview: Senator Ted Kanavas 6WTN Interview: Senator Ted Kanavas 7WTN Interview: Senator Ted Kanavas 8
(Date:4/2/2015)... 2, 2015 According to preliminary ... to somewhat higher than 125 MSEK. This exceeds the ... 2014 that revenues for Q1 2015 would be in ... for Q4 2014. The operating result for the first ... complete interim report will as previously communicated be published ...
(Date:4/1/2015)... , April 1, 2015   Medisafe ™, ... million users across iOS and Android ... begun integrating biofeedback into the platform to allow patients ... outcomes. For the first time, patients will be able ... a dose impacts important biometrics, such as glucose levels ...
(Date:3/30/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ... Gesture Recognition Market in Automotive Sector 2014-2018" report ... Global Gesture Recognition market in Automotive Sector to grow ... Gesture recognition is the ability of a ... an individual. Gesture recognition technology can be 2D-based or ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... New Mexico, March 3, 2010Two teams of researchersincluding Los ... Sydeaka Watson, and James Szingerhave announced an HIV vaccination ... and depth of immune responses in rhesus monkeys. Rhesus ... testing HIV vaccines. The research appeared in two ...
... release is available in Spanish . ... nutrition savvyplus physical fitness skillsare emerging from scientific studies ... example, investigators Craig A. Johnston, John P. Foreyt and ... of their earlier studies in which many of their ...
... Far from being a food spoiler, the fluorescent lighting ... fresh spinach, scientists are reporting. The finding could lead ... value of spinach and perhaps other veggies, they suggest ... Agricultural and Food Chemistry . Gene Lester, Donald ...
Cached Biology News:HIV vaccine strategy expands immune responses 2Kids lose pounds, gain fitness in Houston study 2